1/2/2018

P&G to Give $10 Million to Cincinnati Cancer Center

P&G recently announced a gift that will positively impact countless families around the region.

The Company has committed to give $10 million to support cancer research and outcomes across the Cincinnati area in support of the Cincinnati Cancer Center (CCC), a collaboration of the University of Cincinnati (UC), UC Health and Cincinnati Children’s Hospital Medical Center. This gift will profoundly impact research efforts, and improve the lives of families afflicted by cancer in P&G’s hometown and beyond.

Test tubes

The donation will support recruitment and research enhancements at the CCC as part of the process of accelerating cancer research in advance of the application for National Cancer Institute (NCI) designation.

"NCI-designated cancer centers represent the gold standard of cancer research, treatment and prevention. The opportunity for Greater Cincinnati to join the ranks of cities with an NCI cancer center was a motivating force behind this gift," said Brian Hodgett, P&G's Director of Ohio Government & Community Relations. "At P&G, we share the passion of the Cincinnati Cancer Center for turning the tide against this devastating disease, one that affects our company, and our families and friends. We hope our gift will serve as a bedrock for the movement to bring the national research funding of the NCI to Cincinnati to better understand and treat cancer in our region and the world."

UChealth lab

Dr. David Plas conducts brain tumor research.

Funds from P&G’s gift will support recruitment and hiring of researchers at the Cincinnati Cancer Center, a vital focus area for NCI-designation. The Cincinnati Cancer Center was established in 2011 to leverage the strength of UC, UC Health and Cincinnati Children’s and to link their cancer diagnostics, research, treatment and care operations.

"P&G’s support is invigorating to the work we are doing in Cincinnati," said Michael Fisher, President and CEO of Cincinnati Children’s. "We are thankful that P&G believes in our mission of collaborative, interdisciplinary research and targeted treatment for cancer across the lifespan. With their support, we are further on the path toward NCI-designation."

Cancer diagnostics

Proton beam technology sets CCC apart from the rest—a collaboration of Children's and UC Health.

NCI-designated centers are hubs for cancer research, receiving a greater share of federal funding with access to more clinical trials for patients. They are also a talent draw, spurring industry and development in the surrounding community.

"P&G's investment in the health and development of our region shows the spirit of collaboration that is integral to who we are in Greater Cincinnati," said UC President Neville G. Pinto. "When we come together with shared goals for our community, we can make huge leaps forward in science, in care and in prevention."